August 18, 2008, The Cleveland Plain Dealer, Oops: FBI had, but tossed anthrax type in attack, by Bill Meyer,

August 18, 2008, The Cleveland Plain Dealer, Oops: FBI had, but tossed anthrax type in attack, by Bill Meyer,
August 18, 2008, USA Today, FBI had, then tossed anthrax type used in attacks, by Lara Jakes Jordan And Seth Borenstein, Associated Press Writers,
August 18, 2008, AP, FBI had, then tossed anthrax type used in attacks,
August 19, 2008, Washington Examiner, FBI had, then tossed, anthrax type used in attacks,




August 18, 2008, The Cleveland Plain Dealer, Oops: FBI had, but tossed anthrax type in attack, by Bill Meyer,


AP
Frederick, Md., police wait on the porch at the home of Bruce E. Ivins, 62, who died of an apparent overdose of prescription Tylenol mixed with codeine Aug. 1. Ivins, a top U.S. biodefense researcher who, according to his brother, was being aggressively pursued by the FBI in connection with a series of anthrax mailings after the Sept. 11, 2001, terrorist attacks apparently committed suicide.

WASHINGTON -- FBI scientists early on had -- but destroyed -- the unique strain of anthrax used in deadly 2001 mail attacks that years later would lead them to Dr. Bruce Ivins, the government's top suspect in the biggest bioterrorism case in the United States.

FBI Assistant Director Vahid Majidi said Monday the initial anthrax sample that Ivins took from his Army lab in February 2002 and gave investigators did not meet court-ordered conditions for its preparation and collection.

In a briefing for reporters, Majidi said the sample kept at the FBI lab was destroyed because the bureau believed it might not have been allowed as evidence at trial.

"Looking at hindsight, obviously we would do things differently today," Majidi said.

Ivins, 62, took a fatal dose of acetaminophen last month as prosecutors prepared to indict him for murder.

He gave investigators a second sample of anthrax from his lab in April 2002 to comply with standards in a subpoena issued in the case. But that sample contained a different strain than what he submitted two months earlier in what prosecutors call an attempt to deceive or confuse investigators.

Majidi, who heads the FBI office in charge of investigating weapons of mass destruction, led a panel of government and private-sector scientists who detailed the scientific case against Ivins. They credited new ways of looking at the DNA of anthrax to whittle the list of labs and suspects who could have produced it.

That science, which let investigators look for tiny genetic mutations in the kind of anthrax used in the attacks that rattled America in 2001, was only becoming available around 2004 when the FBI seized more samples from the Army's biodefense lab at Fort Detrick, Maryland, Majidi said. Not until then were investigators able to trace strains of genetically unique anthrax back to Ivins, he said.

As part of the February 2002 subpoena, Ivins gave investigators two samples of the unique Ames anthrax strain known as RMR-1029 that he created in his lab. One went to the FBI lab, where it was destroyed. The other went to the lab of Dr. Paul Keim, a geneticist at Northern Arizona University in Flagstaff, Arizona.

Keim still had his RMR-1029 sample in 2006 when the FBI realized it could match Ivins to two batches of anthrax-laced letters that were mailed in the weeks after the Sept. 11, 2001, terror attacks. The anthrax letters killed five and sickened 17 after turning up on Capitol Hill, in newsrooms and postal facilities.

"There were a lot of lessons learned," Majidi said. "Were we perfect? Absolutely not. We've had missteps, and those are the lessons learned. ... It was over the last few years that we were able to incorporate all of the lessons learned that we have throughout this investigation."

One of the targets of the letters was former Senate Democratic leader Tom Daschle, who on Monday called the evidence against Ivins convincing -- even if he is not completely sure the investigation focused on the right person.

In an interview, Daschle praised the investigation and said his two-hour FBI briefing last week was "complete and persuasive." Still, he said, there are some open questions. He said the evidence should be scientifically reviewed.

Daschle said the most compelling evidence to him is the odd, extended hours that the Army scientist kept shortly after the Sept. 11 attacks.

"He had no real explanation for the significant increase," Daschle said. "His only response was that he wanted to hang out there, which was not a very compelling reason."

He said investigators ruled out the other people who had access to Ivins' anthrax based on other information that was available.

"They had stiff alibis or ... they were not in a position to take the material for purposes of this kind," Daschle said. "Each one had a specific disqualifying aspect."

Daschle and fellow Democratic Sen. Patrick Leahy of Vermont both received anthrax-laced letters in their Senate offices. Both senators have received recent briefings from FBI Director Robert Mueller on the evidence against Ivins.
_________________________________________________________________________________

August 18, 2008, USA Today, FBI had, then tossed anthrax type used in attacks, by Lara Jakes Jordan And Seth Borenstein, Associated Press Writers,

WASHINGTON — Months after the deadly 2001 anthrax mailings, FBI scientists had -- but destroyed -- the unique strain of the bacteria used in the attacks that years later would lead them to Dr. Bruce Ivins, now the government's top suspect.

FBI officials admitted Monday that destroying the initial Ivins sample was a mistake, but said it didn't really hinder the investigation because the technique used to trace the source of the anthrax to Ivins had not been developed yet. Luckily, a copy of that first sample was sent to an outside professor, who years later used it to help further link Ivins to the killer strain.

Ivins, 62, took a fatal dose of acetaminophen last month as prosecutors prepared to indict him for murder.

Top FBI officials and a handful of prominent scientists who aided the investigation presented more -- but not all -- of the scientific case against Ivins in a two-hour-and-fifteen-minute news conference to try to quell suspicions of outside scientists, some of whom were friends of the suspect.

At times the officials and scientists contradicted themselves, even down to the number of flasks containing the anthrax Ivins had. They eventually agreed it was one one-liter triangular flask capped with cheesecloth that linked Ivins to the attacks.


"There were a lot of lessons learned," FBI Assistant Director Vahid Majidi said. "Were we perfect? Absolutely not. We've had missteps, and those are the lessons learned. ... It was over the last few years that we were able to incorporate all of the lessons learned that we have throughout this investigation."

The complete genome mapping of the unique killer strain -- the cornerstone of the forensic case -- won't be public for months, maybe more than a year, because it will be published in peer-reviewed scientific journals that take time. The outsiders who had questions about the government's case wanted to see the complete genomic map sooner.

"There are still many nagging questions about this," said Dr. Michael Stebbins, who directs the Federation of American Scientists' biosecurity project and wasn't at the Monday's briefing. "Unfortunately a lot of them are not going to be able to be answered in the immediate future."

Majidi understands that: "I don't think, No. 1, we're ever going to put the suspicions to bed. There's always going to be a spore on the grassy knoll."

FBI officials spent much of their time going into more detail about the specific four mutations in the strain of anthrax that led back to Ivins' Army lab at Fort Detrick, Md. They weren't easy to find, rare like red or green M&Ms in a flask mostly full of blue candies, Majidi said.

FBI officials and scientists had to come up with a technique for looking at the DNA of anthrax to whittle down the list of labs and suspects who could have produced it, creating a new field of forensic microbiology. That scientific technique to connect a lab with a unique strain wasn't available until after the FBI had destroyed its first sample from Ivins.

In February 2002, the FBI sent subpoenas around the world to labs handling the Ames strain of anthrax, which was the strain that killed five people in 2001. They got 1,070 samples and destroyed only one: the first one from Ivins. It was destroyed because Ivins didn't use the proper test tube and growth medium so it may have not been useful as evidence in court, officials said.

Ivins was one of the first to respond to FBI subpoenas, but his sample was deemed useless and he was asked to submit another. He gave investigators a second sample of anthrax from his lab in April 2002 to comply with standards in a subpoena issued in the case. But that sample contained a different strain than what he submitted two months earlier in what prosecutors call an attempt to deceive or confuse investigators

When Ivins sent his initial sample to the FBI, a duplicate went to the lab of Dr. Paul Keim, a geneticist at Northern Arizona University in Flagstaff, Ariz.

Keim still had his RMR-1029 sample in 2006 when the FBI realized it could match Ivins to two batches of anthrax-laced letters that were mailed in the weeks after the Sept. 11, 2001, terror attacks.

Stebbins said the fact that Keim kept his sample was key in building the case, something Keim played down after the news conference.

FBI officials and scientists also played down any significance of the element silicon in the killer anthrax strain, saying it seemed more of a natural occurrence than deliberate weaponizing as once theorized early in the investigation.

One of the targets of the letters was former Senate Democratic leader Tom Daschle, who on Monday called the evidence against Ivins convincing -- even if he is not completely sure the investigation focused on the right person.

In an interview, Daschle praised the investigation and said his two-hour FBI briefing last week was "complete and persuasive." Still, he said, there are some open questions. He said the evidence should be scientifically reviewed.

Daschle said the most compelling evidence to him is the odd, extended hours that the Army scientist kept shortly after the Sept. 11 attacks.

"He had no real explanation for the significant increase," Daschle said. "His only response was that he wanted to hang out there, which was not a very compelling reason."

Daschle and fellow Democratic Sen. Patrick Leahy of Vermont both received anthrax-laced letters in their Senate offices. Both senators have received recent briefings from FBI Director Robert Mueller on the evidence against Ivins.

Associated Press writer Mary Clare Jalonick contributed to this report.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
_________________________________________________________________________________

August 18, 2008, AP, FBI had, then tossed anthrax type used in attacks,

FBI Assistant Director Vahid Majidi said Monday the initial anthrax sample that Ivins took from his Army lab in February 2002 and gave investigators did not meet court-ordered conditions for its preparation and collection.

In a briefing for reporters, Majidi said the sample kept at the FBI lab was destroyed because the bureau believed it might not have been allowed as evidence at trial.

"Looking at hindsight, obviously we would do things differently today," Majidi said.

He gave investigators a second sample of anthrax from his lab in April 2002 to comply with standards in a subpoena issued in the case. But that sample contained a different strain than what he submitted two months earlier in what prosecutors call an attempt to deceive or confuse investigators.

Majidi, who heads the FBI office in charge of investigating weapons of mass destruction, led a panel of government and private-sector scientists who detailed the scientific case against Ivins. They credited new ways of looking at the DNA of anthrax to whittle the list of labs and suspects who could have produced it. ... As part of the February 2002 subpoena, Ivins gave investigators two samples of the unique Ames anthrax strain known as RMR-1029 that he created in his lab. One went to the FBI lab, where it was destroyed. The other went to the lab of Dr. Paul Keim, a geneticist at Northern Arizona University in Flagstaff, Ariz.

Keim still had his RMR-1029 sample in 2006 when the FBI realized it could match Ivins to two batches of anthrax-laced letters that were mailed in the weeks after the Sept. 11, 2001, terror attacks. The anthrax letters killed five and sickened 17 after turning up on Capitol Hill, in newsrooms and postal facilities.

(Excerpt)

_________________________________________________________________________________


August 19, 2008, Washington Examiner, FBI had, then tossed, anthrax type used in attacks,

FBI scientists early on had — but destroyed — the unique strain of anthrax used in the deadly 2001 attacks that years later would lead them to Dr. Bruce Ivins, the government’s top suspect who committed suicide three weeks ago.

FBI Assistant Director Vahid Majidi said Monday that the initial anthrax sample that Ivins took from his Army lab in February 2002 and gave investigators did not meet court-ordered conditions for its preparation and collection.

In a briefing for reporters, Majidi said the sample kept at the FBI lab was destroyed because the bureau believed it might not have been allowed as evidence at trial.

“Looking at hindsight, obviously we would do things differently today,” Majidi said.

The science that let investigators look for tiny genetic mutations in the kind of anthrax used in the attacks was only becoming available around 2004, Majidi said. Not until then did investigators trace strains of genetically unique anthrax back to Ivins’ biodefense lab at Fort Detrick.

“There were a lot of lessons learned,” said Majidi, who heads the FBI office in charge of investigating weapons of mass destruction. “Were we perfect? Absolutely not. We’ve had missteps, and those are the lessons learned. ... It was over the last few years that we were able to incorporate all of the lessons learned that we have throughout this investigation.”

As part of a February 2002 subpoena, Ivins gave investigators two samples of the unique anthrax strain known as RMR-1029 that he created in his lab. One went to the FBI lab, where it was destroyed. The other went to the lab of Dr. Paul Keim, a geneticist at Northern Arizona University in Flagstaff, Ariz.

Keim still had his RMR-1029 sample in 2006 when the FBI realized it could match Ivins to two batches of anthrax-laced letters that were mailed in the weeks after the Sept. 11, 2001, terrorist attacks. The anthrax letters killed five and sickened 17 after turning up on Capitol Hill, in newsrooms and in postal facilities.

Ivins took a fatal dose of acetaminophen last month as prosecutors prepared to indict him on murder charges.